Literature DB >> 14184942

THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS.

K GERZON, E V KRUMKALNS, R L BRINDLE, F J MARSHALL, M A ROOT.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS; BLOOD SUGAR; BRIDGED COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; EXPERIMENTAL LAB STUDY; PHARMACOLOGY; RATS; TOLBUTAMIDE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14184942     DOI： 10.1021/jm00342a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  10 in total

Review 1.  Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?

Authors:  Cornelis J Van der Schyf; Werner J Geldenhuys
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 2.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

4.  Update on the use of memantine in Alzheimer's disease.

Authors:  Robert J van Marum
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

5.  [1-(1-Adamantylamino)ethyl-idene]oxonium methane-sulfonate.

Authors:  Robert Vícha; Marek Nečas; Zuzana Kozubková; Milan Potáček
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-20

6.  Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues.

Authors:  Ghada S Hassan; Ali A El-Emam; Laila M Gad; Alaa Eldin M Barghash
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

7.  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import.

Authors:  Barry Reisberg; Melanie B Shulman
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

Review 8.  Memantine in neurological disorders - schizophrenia and depression.

Authors:  Kamila Czarnecka; Jakub Chuchmacz; Przemysław Wójtowicz; Paweł Szymański
Journal:  J Mol Med (Berl)       Date:  2021-01-14       Impact factor: 4.599

9.  Opening of the Diamondoid Cage upon Ionization Probed by Infrared Spectra of the Amantadine Cation Solvated by Ar, N2 , and H2 O.

Authors:  Martin Andreas Robert George; Otto Dopfer
Journal:  Chemistry       Date:  2022-06-20       Impact factor: 5.020

Review 10.  Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis.

Authors:  Diana Machado; Miriam Girardini; Miguel Viveiros; Marco Pieroni
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.